"Innovation starts with hope of a better future" Arman Enekvint, resident doctor in ophthalmology at Sahlgrenska University Hospital, is participating in Sahlgrenska’s Innovation & H...
MYoroface breaks new ground in UK MYoroface, company within Sahlgrenska Science Park community, has been granted the right to provide its product IQoro on prescription in the UK as of 1 May 2022.
Key to success for healthtech companies Collaboration within the industry and with other industries is a key success factor for healthtech companies in West Sweden. That’s accor...
Sahlgrenska Science Park facilitates recruitments through Jobbsprånget Three startups in the community have recruited new employees after Sahlgrenska Science Park facilitated connections with Jobbsprånget.
The award gave them wind in their sails Last year, Boneprox won the HealthTech Award in tough competition. “The prize put wind in our sails, increased our credibility and create...
VIDEM raises 5 MSEK for pioneering infectious disease diagnostics PCR tests have cost the Swedish government SEK 22 billion throughout the pandemic. A new method will enable cheaper, faster and more accu...